Scarica l'app Stockscreener
26.45
4.13%
1.05
Dopo l'orario di chiusura:
26.47
0.02
+0.08%
Precedente Chiudi:
$25.40
Aprire:
$25.36
Volume 24 ore:
2.36M
Relative Volume:
1.40
Capitalizzazione di mercato:
$1.51B
Reddito:
$308.05M
Utile/perdita netta:
$-95.57M
Rapporto P/E:
-15.38
EPS:
-1.72
Flusso di cassa netto:
$-58.34M
1 W Prestazione:
+6.52%
1M Prestazione:
+14.01%
6M Prestazione:
-15.60%
1 anno Prestazione:
-50.21%
Intervallo 1D:
$25.00
$27.81
Intervallo di 1 settimana:
$24.25
$27.81
Portata 52W:
$19.35
$66.85
Procept Biorobotics Corp Stock (PRCT) Company Profile
Nome
Procept Biorobotics Corp
Settore
Industria
Telefono
(650) 232-9832
Indirizzo
150 BAYTECH DRIVE, SAN JOSE
Compare PRCT vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
PRCT
Procept Biorobotics Corp
|
26.45 | 1.45B | 308.05M | -95.57M | -58.34M | -1.72 |
ABT
Abbott Laboratories
|
82.56 | 146.87B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
282.58 | 109.33B | 25.27B | 3.34B | 4.57B | 8.6358 |
MDT
Medtronic Plc
|
74.54 | 97.77B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
53.37 | 80.16B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
77.17 | 46.04B | 6.30B | 1.07B | 1.09B | 1.8406 |
Procept Biorobotics Corp Stock (PRCT) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-03-06 | Iniziato | Robert W. Baird | Neutral |
| 2026-02-26 | Downgrade | BofA Securities | Neutral → Underperform |
| 2026-02-26 | Downgrade | Oppenheimer | Outperform → Perform |
| 2025-12-12 | Iniziato | UBS | Buy |
| 2025-12-08 | Downgrade | BofA Securities | Buy → Neutral |
| 2025-09-02 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2025-07-09 | Iniziato | Stephens | Overweight |
| 2025-07-07 | Iniziato | Oppenheimer | Perform |
| 2024-12-02 | Iniziato | Morgan Stanley | Overweight |
| 2024-11-14 | Iniziato | Jefferies | Hold |
| 2023-08-11 | Iniziato | Piper Sandler | Overweight |
| 2023-05-31 | Iniziato | William Blair | Outperform |
| 2022-10-31 | Iniziato | BTIG Research | Neutral |
| 2022-10-25 | Iniziato | Truist | Buy |
| 2022-09-02 | Iniziato | Wells Fargo | Overweight |
| 2022-07-15 | Iniziato | KeyBanc Capital Markets | Overweight |
| 2022-06-23 | Iniziato | B. Riley Securities | Buy |
| 2021-10-11 | Iniziato | BofA Securities | Buy |
| 2021-10-11 | Iniziato | Cowen | Outperform |
| 2021-10-11 | Iniziato | Goldman | Neutral |
| 2021-10-11 | Iniziato | Guggenheim | Buy |
| 2021-10-11 | Iniziato | SVB Leerink | Outperform |
Mostra tutto
Procept Biorobotics Corp Borsa (PRCT) Ultime notizie
Should PROCEPT BioRobotics’ Reaffirmed 2026 Outlook Amid Wider Losses Require Action From PRCT Investors? - simplywall.st
C WorldWide Group Holding A S Purchases 225,000 Shares of PROCEPT BioRobotics Corporation $PRCT - MarketBeat
UBS Group AG Increases Position in PROCEPT BioRobotics Corporation $PRCT - MarketBeat
A Look At PROCEPT BioRobotics (PRCT) Valuation After Q1 Earnings And Reaffirmed Growth Guidance - Sahm
Does Stronger Aquablation Tailwinds And Reaffirmed 2026 Guidance Change The Bull Case For PROCEPT (PRCT)? - Sahm
PRCT SEC FilingsProcept Biorobotics Corp 10-K, 10-Q, 8-K Forms - Stock Titan
PRCT Stock Price, Quote & Chart | PROCEPT BIOROBOTICS CORP (NASDAQ:PRCT) - ChartMill
How The PROCEPT BioRobotics (PRCT) Investment Story Is Shifting After Q4 Miss And Guidance Reset - Yahoo Finance
Latest PRCT NewsPROCEPT BioRobotics Corporation Announces C... - Stock Titan
Assessing PROCEPT BioRobotics (PRCT) Valuation After Mixed Q1 2026 Results And Share Price Weakness - Sahm
PROCEPT BioRobotics Corp Q1 2026 Financial Results and SEC 10-Q Filing Highlights - Minichart
PROCEPT BioRobotics (PRCT)’s Growth Narrative Improves Following Aquablation Upgrade and HYDROS Launch - Insider Monkey
Analysts Offer Insights on Healthcare Companies: PROCEPT BioRobotics (PRCT), AbbVie (ABBV) and Humana (HUM) - The Globe and Mail
PROCEPT BioRobotics Q1 Loss Deepens To US$0.56 EPS And Tests Bullish Revenue Narratives - simplywall.st
Procept Biorobotics Charts Growth Amid Profit Pressures - TipRanks
PRCT Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PROCEPT BioRobotics (PRCT) CTO reports share and option stakes - Stock Titan
PROCEPT BioRobotics (NASDAQ: PRCT) Q1 2026 revenue rises 20% - Stock Titan
PROCEPT BioRobotics to Attend Three Upcoming Investor Conferences in May & June - Moomoo
PROCEPT BioRobotics® to Attend Three Upcoming Investor Conferences in May & June - The Manila Times
PROCEPT BioRobotics schedules 3 investor conference appearances - Stock Titan
10 Best Robotics Stocks to Buy Under $30 - Insider Monkey
PROCEPT BioRobotics (NASDAQ:PRCT) Shares Gap UpStill a Buy? - MarketBeat
Vanguard (NASDAQ: PRCT) holds 2.82M shares, a 5% stake - Stock Titan
Procept projects $390M-$410M 2026 revenue as Hydros pricing guides $450K-$460K for rest of year - MSN
Procept BioRobotics price target raised to $35 from $28 at Piper Sandler - TipRanks
PROCEPT BioRobotics Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
Earnings Call Summary | PROCEPT BioRobotics(PRCT.US) Q1 2026 Earnings Conference - Moomoo
PROCEPT BioRobotics (NASDAQ:PRCT) Posts Quarterly Earnings Results, Misses Estimates By $0.01 EPS - MarketBeat
PROCEPT BioRobotics Corporation (PRCT) reports Q1 loss, tops revenue estimates - MSN
PROCEPT BioRobotics Q1 Earnings Call Highlights - MarketBeat
Procept BioRobotics reports Q1 EPS (56c), consensus (55c) - TipRanks
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations By Investing.com - Investing.com South Africa
Earnings call transcript: Procept Biorobotics Q1 2026 beats EPS expectations - Investing.com
12,200 U.S. procedures put PROCEPT BioRobotics' systems to work in Q1 - Stock Titan
PROCEPT BioRobotics Corporation (PRCT) Reports Q1 Loss, Tops Revenue Estimates - Yahoo Finance
PROCEPT BioRobotics Corporation (PRCT) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Earnings Flash (PRCT) PROCEPT BioRobotics Corporation Reports Q1 Revenue $83.1M, vs. FactSet Est of $80.5M - marketscreener.com
PROCEPT BioRobotics (Nasdaq: PRCT) grows Q1 2026 revenue 20% but stays loss-making - Stock Titan
PROCEPT BioRobotics Reports First Quarter 2026 Financial Results - The Manila Times
Procept Biorobotics in the spotlight as Q1 earnings test turnaround - Investing.com UK
Procept Biorobotics in the spotlight as Q1 earnings test turnaround By Investing.com - Investing.com Australia
Procept Biorobotics Corporation Reaffirms Earnings Guidance for the Year Ending December 31, 2026 - marketscreener.com
Robotics Stocks To Follow TodayApril 28th - MarketBeat
PROCEPT BioRobotics (PRCT) Price Target Decreased by 16.88% to 55.27 - MSN
PROCEPT BioRobotics (PRCT) price target decreased by 37.60% to 33.58 - MSN
59,200 Shares in PROCEPT BioRobotics Corporation $PRCT Bought by B. Metzler seel. Sohn & Co. AG - MarketBeat
PROCEPT BioRobotics (NASDAQ:PRCT) Rating Increased to Sell at Wall Street Zen - MarketBeat
Procept Biorobotics Corp Azioni (PRCT) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
3.34%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):